Welltower (NYSE:HCN) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Saturday.

A number of other equities analysts also recently weighed in on the stock. Stephens set a $70.00 target price on shares of Welltower and gave the company a “buy” rating in a research note on Friday. Zacks Investment Research downgraded shares of Welltower from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Mizuho reaffirmed a “hold” rating and set a $67.00 target price on shares of Welltower in a research note on Monday, December 11th. Capital One Financial raised shares of Welltower from an “equal weight” rating to an “overweight” rating in a research note on Wednesday, November 8th. Finally, Stifel Nicolaus decreased their target price on shares of Welltower from $75.00 to $74.00 and set a “buy” rating for the company in a research note on Friday, November 3rd. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $72.92.

Welltower (NYSE HCN) opened at $59.16 on Friday. Welltower has a one year low of $58.98 and a one year high of $78.17. The firm has a market cap of $21,910.31, a P/E ratio of 23.85, a price-to-earnings-growth ratio of 3.92 and a beta of 0.25. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.79.

Welltower (NYSE:HCN) last announced its earnings results on Tuesday, November 7th. The real estate investment trust reported $1.08 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.03. Welltower had a net margin of 22.67% and a return on equity of 7.45%. The business had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter last year, the firm earned $1.16 earnings per share. The business’s revenue for the quarter was up 1.1% on a year-over-year basis. equities research analysts expect that Welltower will post 4.24 EPS for the current fiscal year.

In other news, Director Gary Whitelaw purchased 1,420 shares of the business’s stock in a transaction dated Tuesday, November 21st. The shares were purchased at an average price of $68.39 per share, for a total transaction of $97,113.80. Following the completion of the acquisition, the director now directly owns 1,420 shares in the company, valued at approximately $97,113.80. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.19% of the company’s stock.

Several large investors have recently bought and sold shares of HCN. Franklin Resources Inc. grew its holdings in shares of Welltower by 11.8% during the second quarter. Franklin Resources Inc. now owns 452,545 shares of the real estate investment trust’s stock valued at $33,873,000 after buying an additional 47,758 shares during the last quarter. Martingale Asset Management L P purchased a new stake in shares of Welltower during the second quarter valued at approximately $210,000. Norinchukin Bank The boosted its holdings in Welltower by 7.9% in the second quarter. Norinchukin Bank The now owns 25,410 shares of the real estate investment trust’s stock worth $1,902,000 after purchasing an additional 1,851 shares during the last quarter. Comerica Securities Inc. boosted its holdings in Welltower by 6.0% in the second quarter. Comerica Securities Inc. now owns 5,180 shares of the real estate investment trust’s stock worth $388,000 after purchasing an additional 295 shares during the last quarter. Finally, Bahl & Gaynor Inc. boosted its stake in shares of Welltower by 3.0% during the 2nd quarter. Bahl & Gaynor Inc. now owns 18,178 shares of the real estate investment trust’s stock worth $1,217,000 after acquiring an additional 533 shares during the last quarter. Hedge funds and other institutional investors own 86.46% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Welltower (HCN) Rating Increased to Buy at ValuEngine” was published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/welltower-hcn-rating-increased-to-buy-at-valuengine/1808027.html.

Welltower Company Profile

Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Welltower (NYSE:HCN)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with Analyst Ratings Network's FREE daily email newsletter.